Childhood depression: Diagnosis and treatment strategies in general pediatrics

Pediatric Annals

Volumn 30, Issue 3, 2001, Pages 130-137

  Shoaf, T L ^a   Emslie, G J ^a   Mayes, T L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; CYTOCHROME P450 1A2; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DOPAMINE; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CHILDHOOD DISEASE; CLINICAL EXAMINATION; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DRUG CHOICE; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; NAUSEA; PSYCHOLOGIC ASSESSMENT; REVIEW; SOCIAL SUPPORT; TREATMENT INDICATION; VERTIGO;

EID: 0035103055     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20010301-06     Document Type: Review

References (33)

1. Pharmacotherapy of depression: A review of current evidence and practical clinical directions
2. Depressive symptoms by self-report in adolescence: Phase I of the development of a questionnaire for depression by self-report
3. Adult outcomes of childhood and adolescent depression: I. Psychiatric status
4. The Children's Depression Inventory (CDI)
5. A controlled family history study of prepubertal major depressive disorder
6. Updates in the pharmacologic treatment of childhood depression
7. The effect of depression and learning disabilities on school behavior problems
8. A diagnostic approach to developmental specific learning disorders
9. A clinical psychotherapy trial for adolescent depression comparing cognitive, family and supportive therapy
10. An open multi-site pilot study of cognitive therapy for depressed adolescents
11. Interpersonal psychotherapy for depressed adolescents: A one-year naturalistic follow-up study
12. Adaptations of cognitive therapy for depressed adolescents
13. Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: A randomized trial of a group cognitive intervention
14. Comparison of cognitive-behavioral, relaxation, and self-modeling interventions for depression among middle-school students
15. Cognitive-behavioral treatment for depressed adolescents
16. A course in coping: A cognitive-behavioral approach to the treatment of adolescent depression
17. A comparison of cognitive-behavioral therapy and relaxation training for the treatment of depression in adolescents
18. A double-blind, randomized placebo-controlled trial of fluoxetine in children and adolescents with depression
19. Safety of paroxetine and imipramine in the treatment of adolescent depression
20. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder
21. Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis
22. Evidence of familial association between attention deficit disorder and major affective disorders
23. Fluoxetine in child and adolescent depression: Acute and maintenance treatment
24. Fluoxetine side effects
25. Depression in children and adolescents: A guide to diagnosis and treatment
26. Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia
27. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression
28. Venlafaxine for treatment-resistant unipolar depression
29. Response of anxiety and agitation symptoms during nefazodone treatment of major depression
30. The effects of nefazodone on sleep architecture in depression
31. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine